Measuring Estrogens at Low Levels in Plasma

Analytical Method for Low-Level Estrogen Measurement in Plasma

Importance of the Topic

Precise quantification of estrone and estradiol at picomolar concentrations is critical for endocrine research in various populations, including pre-pubescent children, postmenopausal women, and cancer patients undergoing aromatase inhibitor therapy. Conventional immunoassays often suffer from cross-reactivity and limited sensitivity, leading to unreliable data and compromised study conclusions. A robust, selective, and sensitive analytical approach enables more accurate assessment of hormone levels and supports investigations into reproductive health and disease mechanisms.

Objectives and Study Overview

The primary objective was to establish a streamlined assay for simultaneous measurement of estrone (E1) and estradiol (E2) in human plasma at low picomolar levels. The study focused on integrating online solid-phase extraction (SPE) with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to achieve high selectivity, reduce matrix effects, and maintain a short analysis time suitable for clinical research workflows.

Methodology and Instrumentation

The method employed an ACQUITY UPLC system coupled to a Xevo TQ-S mass spectrometer operated in negative ion mode. Key parameters included:

• Chromatographic column: ACQUITY UPLC C18 SB, 1.8 µm, 2.1 × 30 mm
• Online SPE: MassTrak C18 OSM cartridge with ACQUITY UPLC Online SPE Manager
• Sample prep: 250 µL plasma extracted with 900 µL methyl tert-butyl ether (MTBE), dried, and reconstituted in 100 µL 40% methanol
• SPE conditioning: 0.5 mL methanol, 0.5 mL water; sample loading: 75 µL plus 0.5 mL water; wash: 0.5 mL 30% methanol; elution directly onto the analytical column

Main Results and Discussion

The developed assay provided:

• Lower limits of quantitation (LLOQ): 6 pmol/L for estrone, 10 pmol/L for estradiol
• Linear dynamic range from low picomolar to nanomolar concentrations (up to 2000 nmol/L for estradiol)
• Run time of less than 5 minutes per sample
• Minimal matrix effects and improved selectivity due to integrated SPE cleanup

The use of deuterated internal standards ensured accurate quantitation across diverse sample matrices.

Practical Benefits and Applications

This method offers several advantages for research and quality control settings:

• Simultaneous determination of E1 and E2 in a single injection
• Rapid sample throughput suitable for large-scale studies
• Elimination of derivatization steps, reducing preparation time and potential errors
• High sensitivity supports measurement in populations with very low hormone levels

Future Trends and Applications

Emerging directions include expanding the panel to cover additional steroid hormones, integrating automated sample handling for high-throughput screening, and leveraging ultra-high-resolution mass spectrometry for improved specificity. Advances in ionization technologies and AI-driven data processing will further enhance assay robustness and speed.

Conclusion

The fully integrated online SPE-LC-MS/MS method delivers a fast, sensitive, and highly selective solution for quantifying estrone and estradiol at low concentrations in human plasma. Its streamlined workflow and excellent analytical performance make it a valuable tool for endocrine research and clinical studies.

Reference

Waters Corporation. Measuring Estrogens at Low Levels in Plasma. Application Note 720004616EN. January 2014.